 However, this rule failed to motivate many drug companies to conduct additional pediatric drug trials.In 1997, the FDA proposed a rule to require pediatric drug trials from the sponsors of New Drug Applications.However, this new rule was successfully preempted in federal court as exceeding the FDA's statutory authority.